Azacitidine Injection, Powder, Lyophilized, For Solution
Product Images NDC 69539-112

This text is a pharmaceutical label for Azacitidine for Injection, a cytotoxic agent used for subcutaneous and intravenous use. The single-dose vial contains azacitidine 100 mg and mannitol 100 mg. The text provides dosage information, storage instructions, and details about the manufacturer and distributor.*

This is a survival analysis output comparing two groups (AZA and CCR) using the log-rank statistical test. The hazard ratio (HR) is 0.5895 with a 95% confidence interval of 0.43-0.77, indicating a significant difference between the groups in terms of survival. The analysis shows that there were 82 deaths in the AZA group and 113 deaths in the CCR group. The plot displays the survival curves for both groups over time in months, with the number of individuals at risk at different time points.*

This is a description of a sterile single-dose vial containing 100 mg of azacitidine and 100 mg of mannitol. The recommended dosage information is available in the prescribing information for dosing and administration. It is a cytotoxic agent intended for subcutaneous and intravenous use only. The vial should be discarded if any portion is unused and kept out of reach of children. The storage temperature should be maintained at 25°C with excursions permitted between 15°-30°C. The product is manufactured by MSN Laboratories Private Limited in India and distributed by MSN Pharmaceuticals Inc. in Piscataway, NJ. The vial is for prescription use only with NDC 69539-112-01.*